Taiji Ryosuke, Nishiofuku Hideyuki, Tanaka Toshihiro, Minamiguchi Kiyoyuki, Fukuoka Yasushi, Saito Natsuhiko, Taguchi Hidehiko, Matsumoto Takeshi, Marugami Nagaaki, Hirai Toshiko, Kichikawa Kimihiko
Department of Radiology, Nara Medical University, Kashihara, Nara, Japan.
J Clin Imaging Sci. 2021 Mar 15;11:15. doi: 10.25259/JCIS_6_2020. eCollection 2021.
The objective of the study is to determine a parameter on the time-intensity curve (TIC) of dynamic contrast-enhanced ultrasonography (DCE-US) that best correlates with tumor growth and to evaluate whether the parameter could correlate with the early response to irinotecan in a rat liver tumor model.
Twenty rats with tumors were evaluated (control: Saline, = 6; treatment: Irinotecan, = 14) regarding four parameters from TIC: Peak intensity (PI), k value, slope (PI × k), and time to peak (TTP). Relative changes in maximum tumor diameter between day 0 and 10, and parameters in the first 3 days were evaluated. The Mann-Whitney U-test was used to compare differences in tumor size and other parameters. Pearson's correlation coefficients (r) between tumor size and parameters in the control group were calculated. In the treatment group, relative changes of parameters in the first 3 days were compared between responder and non-responder (<20% and ≥20% increase in size on day 10, respectively).
PI, k value, PI × k, and TTP significantly correlated with tumor growth ( = 0.513, 0.911, 0.665, and 0.741, respectively). The mean RC in k value among responders ( = 6) was significantly lower than non-responders ( = 8) (mean k value, 4.96 vs. 72.5; = 0.003).
Parameters of DCE-US could be a useful parameter for identifying early response to irinotecan.
本研究的目的是确定动态对比增强超声(DCE-US)时间-强度曲线(TIC)上与肿瘤生长最相关的参数,并评估该参数是否与大鼠肝肿瘤模型中对伊立替康的早期反应相关。
对20只患有肿瘤的大鼠进行评估(对照组:生理盐水,n = 6;治疗组:伊立替康,n = 14),涉及TIC的四个参数:峰值强度(PI)、k值、斜率(PI×k)和达峰时间(TTP)。评估第0天和第10天之间最大肿瘤直径的相对变化以及前3天的参数。采用Mann-Whitney U检验比较肿瘤大小和其他参数的差异。计算对照组中肿瘤大小与参数之间的Pearson相关系数(r)。在治疗组中,比较反应者和无反应者(分别为第10天肿瘤大小增加<20%和≥20%)前3天参数的相对变化。
PI、k值、PI×k和TTP与肿瘤生长显著相关(分别为r = 0.513、0.911、0.665和0.741)。反应者(n = 6)的k值平均相对变化显著低于无反应者(n = 8)(平均k值,4.96对72.5;P = 0.003)。
DCE-US参数可能是识别对伊立替康早期反应的有用参数。